trial

ECT Schizophrenia Serotonin Study

NCTId NCT00278668
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Unknown
Enrollment 15 (estimated)
Sponsored by Sha'ar Menashe Mental Health Center
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
15 (estimated)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2006-10
Primary completion
—
Eligibility
ALL · 18 Years · 55 Years

Interventions & indications

Drugs
—

Sponsors

Sha'ar Menashe Mental Health CenterLead Sponsor

Investigators

3
Avi Peled, MDPrincipal Investigator
Ilan Modai, M.D. MHAPrincipal Investigator
Moshe Rehavi, Ph.D.Principal Investigator

Sites

0 total

Facts & assertions

3 sourced
Enrollment
15
Phase
NA
Status
UNKNOWN
relationships
The graph out of here
lead_sponsor
Sha'ar Menashe Mental Health Center
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Avi Peled, MD
person
Ilan Modai, M.D. MHA
person
Moshe Rehavi, Ph.D.
person